QR-koodi

The prognostic impact of KRAS, TP53, STK11 and KEAP1 mutations and their influence on the NLR in NSCLC patients treated with immunotherapy

Background: PD-L1 expression is used to predict NSCLC response to ICIs, but its performance is suboptimal. The impact of KRAS mutations in these patients is unclear. Studies evaluating co-mutations in TP53, STK11 and KEAP1 as well as the NLR showed that they may predict the benefit of ICIs. Patients...

Täydet tiedot

Tallennettuna:
Päätekijät: Francis Proulx-Rocray, Bertrand Routy, Rami Nassabein, Wiam Belkaid, Danh Tran-Thanh, Julie Malo, Marion Tonneau, Omar El Ouarzadi, Marie Florescu, Mustapha Tehfe, Normand Blais
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Elsevier 2023-01-01
Sarja:Cancer Treatment and Research Communications
Aiheet:
NSCLC
Immunotherapy
KRAS
STK11
KEAP1
Linkit:http://www.sciencedirect.com/science/article/pii/S2468294223000898
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia